We are live on ! Find out more
NVAX icon

Novavax
NVAX

81 hedge funds and large institutions have $35.7M invested in Novavax in 2019 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 10 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

210% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 10

166% more call options, than puts

Call options by funds: $13.6M | Put options by funds: $5.12M

0.88% more ownership

Funds ownership: 28.74% → 29.62% (+0.88%)

0% more funds holding

Funds holding: 81 → 81 (0)

0% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 11

10% less capital invested

Capital invested by funds: $39.7M → $35.7M (-$3.95M)

Holders
81
Holders Change
–
Holders Change %
0%
% of All Funds
1.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
31
Reduced
10
Closed
11
Calls
$13.6M
Puts
$5.12M
Net Calls
+$8.51M
Net Calls Change
-$6.3M

Top Buyers

1
JP Morgan Chase
JP Morgan Chase
New York
+$1.51M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$800K
3
BlackRock
BlackRock
New York
+$479K
4
WG
Winton Group
United Kingdom
+$418K
5
Northern Trust
Northern Trust
Illinois
+$271K

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$877K
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$590K
3
OTPPB
Ontario Teachers' Pension Plan Board
Ontario, Canada
-$510K
4
ARTA
A.R.T. Advisors
New York
-$435K
5
Deutsche Bank
Deutsche Bank
Germany
-$409K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$9.43M +$479K +87,437 +5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$7.76M +$800K +146,168 +10%
Morgan Stanley
3
Morgan Stanley
New York
$2.48M -$877K -160,288 -25%
State Street
4
State Street
Massachusetts
$2.13M +$77K +14,066 +3%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$1.82M +$107K +19,476 +6%
Northern Trust
6
Northern Trust
Illinois
$1.44M +$271K +49,573 +21%
JP Morgan Chase
7
JP Morgan Chase
New York
$1.42M +$1.51M +275,215 +4,028%
RSCM
8
Rock Springs Capital Management
Maryland
$816K – – –
Charles Schwab
9
Charles Schwab
California
$700K +$113K +20,734 +17%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$668K +$167K +30,501 +30%
N
11
Nuveen
North Carolina
$486K +$49.9K +9,126 +10%
Creative Planning
12
Creative Planning
Kansas
$464K +$71.7K +13,101 +17%
Two Sigma Advisers
13
Two Sigma Advisers
New York
$389K -$590K -107,735 -58%
WG
14
Winton Group
United Kingdom
$384K +$418K +76,399 New
CS
15
Credit Suisse
Switzerland
$294K +$93.6K +17,095 +41%
AC
16
Avenir Corporation
Virginia
$279K +$242K +44,300 +392%
VF
17
Virtu Financial
New York
$253K -$113K -20,694 -29%
Wells Fargo
18
Wells Fargo
California
$252K +$51.4K +9,395 +23%
Bank of Montreal
19
Bank of Montreal
Ontario, Canada
$248K +$260K +47,449 +2,435%
SG Americas Securities
20
SG Americas Securities
New York
$235K -$12.1K -2,211 -5%
BWCS
21
Beirne Wealth Consulting Services
Connecticut
$233K +$254K +46,500 New
Swiss National Bank
22
Swiss National Bank
Switzerland
$219K – – –
California State Teachers Retirement System (CalSTRS)
23
California State Teachers Retirement System (CalSTRS)
California
$181K – – –
Goldman Sachs
24
Goldman Sachs
New York
$179K -$9.4K -1,717 -5%
Brown Advisory
25
Brown Advisory
Maryland
$179K +$58.3K +10,650 +42%
1
2 3 4

NVAX Hedge Fund Activity: Q3 2019 in Review

81 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q3 2019, worth a combined $35.7M — down 10% from $39.7M a quarter earlier.

Fund positioning in NVAX was balanced in Q3 2019: 11 funds opened new positions, 11 closed out, 31 added to existing stakes and 10 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $1.51M. The largest seller was Morgan Stanley, cutting an estimated $877K.

  • 81 institutional investors held Novavax (NVAX) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $35.7M of Novavax stock for Q3 2019, down 10% quarter-over-quarter.
  • 11 funds opened new Novavax positions in Q3 2019 and 11 closed out, a net change of 0 holders.
  • The largest Novavax buyer in Q3 2019 was JP Morgan Chase, an estimated $1.51M added.
  • The largest Novavax seller in Q3 2019 was Morgan Stanley, an estimated $877K sold.

Based on aggregated 13F filings for Q3 2019.